Wall Street Analysts Believe Pharming Group (PHAR) Could Rally 81.71%: Here's is How to Trade — Positive

PHAR   Zacks Investment Research — November 26, 2025

The mean of analysts' price targets for Pharming Group (PHAR) points to an 81.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Wall Street Analysts Believe Pharming Group (PHAR) Could Rally 81.71%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news Wall Street Analysts Think OrthoPediatrics (KIDS) Could Surge 26.45%: Read This Before Placing a Bet

Does SkyWest (SKYW) Have the Potential to Rally 34.49% as Wall Street Analysts Expect? — Positive

SKYW   Zacks Investment Research — November 26, 2025

The mean of analysts' price targets for SkyWest (SKYW) points to a 34.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Does SkyWest (SKYW) Have the Potential to Rally 34.49% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 58.5% in Amicus Therapeutics (FOLD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news Wall Street Analysts Think Amicus Therapeutics (FOLD) Could Surge 58.46%: Read This Before Placing a Bet

The mean of analysts' price targets for Compass Therapeutics, Inc. (CMPX) points to a 154.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Wall Street Analysts Believe Compass Therapeutics, Inc. (CMPX) Could Rally 154.09%: Here's is How to Trade

Wall Street Analysts Believe Crexendo (CXDO) Could Rally 27.87%: Here's is How to Trade — Positive

CXDO   Zacks Investment Research — November 26, 2025

The average of price targets set by Wall Street analysts indicates a potential upside of 27.9% in Crexendo (CXDO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news Wall Street Analysts Believe Crexendo (CXDO) Could Rally 27.87%: Here's is How to Trade

Wall Street Analysts Think PRA Group (PRAA) Could Surge 41.95%: Read This Before Placing a Bet — Positive

PRAA   Zacks Investment Research — November 26, 2025

The mean of analysts' price targets for PRA Group (PRAA) points to a 42% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Wall Street Analysts Think PRA Group (PRAA) Could Surge 41.95%: Read This Before Placing a Bet

Wall Street Analysts Believe Abacus Life, Inc. (ABL) Could Rally 110.27%: Here's is How to Trade — Positive

ABL   Zacks Investment Research — November 26, 2025

The mean of analysts' price targets for Abacus Life, Inc. (ABL) points to an 110.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Wall Street Analysts Believe Abacus Life, Inc. (ABL) Could Rally 110.27%: Here's is How to Trade

Deere Not Out of the Woods Yet. Here's Why the Stock is Falling Today. — Negative

DE   Investopedia — November 26, 2025

Shares of Deere & Company (DE) fell Wednesday morning after the maker of large farm and construction equipment gave a weak forecast and warned that “difficult market conditions” will continue for a while longer.

image for news Deere Not Out of the Woods Yet. Here's Why the Stock is Falling Today.

L.B. Foster Company: Despite Some Challenges, This Play Is Undervalued — Positive

FSTR   Seeking Alpha — November 26, 2025

L.B. Foster Company remains a "Buy" as strong order flow and attractive valuation support further upside despite mixed recent financials. FSTR's Infrastructure Solutions segment is thriving, offsetting weakness in Rail, Technologies, and Services, with growth driven by steel products and protective coatings. Shares are undervalued both absolutely and relative to peers, with low multiples and ongoing share buybacks enhancing shareholder value.

image for news L.B. Foster Company: Despite Some Challenges, This Play Is Undervalued

The online brokerage will launch a futures and derivatives exchange with Susquehanna International Group.

image for news Robinhood Goes All In On Prediction Markets with Susquehanna. The Stock Rises.

Synovus Secures Federal Regulatory Approval for Merger With Pinnacle — Positive

PNFP  SNV   Zacks Investment Research — November 26, 2025

SNV moves closer to its $8.6B merger with PNFP after securing Federal Reserve approval and targeting a Jan. 1, 2026, close.

image for news Synovus Secures Federal Regulatory Approval for Merger With Pinnacle

SMR vs. BWXT: Which Nuclear Energy Stock Is a Better Pick Right Now? — Positive

BWXT  SMR   Zacks Investment Research — November 26, 2025

BWX Technology's surging revenues and major defense wins give it a stronger near-term edge over NuScale Power's early-stage revenues and years-out project milestones.

image for news SMR vs. BWXT: Which Nuclear Energy Stock Is a Better Pick Right Now?

Will Soft Gardasil Demand Continue to Dampen Merck's Top Line? — Negative

MRK   Zacks Investment Research — November 26, 2025

MRK faces steep Gardasil declines as China and Japan demand soften, putting pressure on its vaccine portfolio.

image for news Will Soft Gardasil Demand Continue to Dampen Merck's Top Line?

Autodesk Q3 Earnings & Revenues Surpass Estimates, Rise Y/Y — Positive

ADSK   Zacks Investment Research — November 26, 2025

ADSK reports a strong fiscal Q3, with earnings and revenues beating estimates as AECO strength and solid subscription gains drive robust growth.

image for news Autodesk Q3 Earnings & Revenues Surpass Estimates, Rise Y/Y

Johnson & Johnson (JNJ) is a Top-Ranked Momentum Stock: Should You Buy? — Positive

JNJ   Zacks Investment Research — November 26, 2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Johnson & Johnson (JNJ) is a Top-Ranked Momentum Stock: Should You Buy?

Here's Why New York Times Co. (NYT) is a Strong Momentum Stock — Positive

NYT   Zacks Investment Research — November 26, 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

image for news Here's Why New York Times Co. (NYT) is a Strong Momentum Stock

Here's Why FMC Technologies (FTI) is a Strong Momentum Stock — Positive

FTI   Zacks Investment Research — November 26, 2025

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

image for news Here's Why FMC Technologies (FTI) is a Strong Momentum Stock

Affiliated Managers Group (AMG) is a Top-Ranked Momentum Stock: Should You Buy? — Positive

AMG   Zacks Investment Research — November 26, 2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Affiliated Managers Group (AMG) is a Top-Ranked Momentum Stock: Should You Buy?

Here's Why Paymentus (PAY) is a Strong Momentum Stock — Positive

PAY   Zacks Investment Research — November 26, 2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Here's Why Paymentus (PAY) is a Strong Momentum Stock